Should I buy or sell Haleon stock right now?

6 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Haleon in the last year. There are currently 2 hold ratings and 4 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" HLN shares. View HLN analyst ratings or view top-rated stocks .

How have HLN shares performed in 2023?

Haleon's stock was trading at $8.00 at the beginning of the year. Since then, HLN shares have increased by 7.3% and is now trading at $8.58. View the best growth stocks for 2023 here .

Are investors shorting Haleon?

Haleon saw a drop in short interest during the month of October. As of October 31st, there was short interest totaling 21,050,000 shares, a drop of 7.1% from the October 15th total of 22,660,000 shares. Based on an average trading volume of 5,310,000 shares, the days-to-cover ratio is currently 4.0 days. Approximately 0.5% of the shares of the stock are sold short. View Haleon's Short Interest .

When is Haleon's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, March 18th 2024. View our HLN earnings forecast .

How were Haleon's earnings last quarter?

Haleon plc (NYSE:HLN) released its quarterly earnings results on Thursday, November, 2nd. The company reported $0.10 earnings per share for the quarter. The firm earned $3.54 billion during the quarter.

How often does Haleon pay dividends? What is the dividend yield for Haleon?

Haleon announced a -- dividend on Wednesday, August 2nd. Shareholders of record on Friday, August 25th will be paid a dividend of $0.046 per share on Thursday, October 5th. This represents a yield of 1.3%. The ex-dividend date is Thursday, August 24th. Read our dividend analysis for HLN .

Is Haleon a good dividend stock?

Haleon (NYSE:HLN) pays an annual dividend of $0.09 per share and currently has a dividend yield of 1.02%. Read our dividend analysis for HLN .

What ETFs hold Haleon's stock?

ETFs with the largest weight of Haleon (NYSE:HLN) stock in their portfolio include VanEck Pharmaceutical ETF (PPH) , Pacer BioThreat Strategy ETF (VIRS) , ClearBridge Focus Value ESG ETF (CFCV) , Horizon Kinetics Medical ETF (MEDX) ,

Who are Haleon's major shareholders?

Haleon's stock is owned by many different retail and institutional investors. Top institutional investors include FMR LLC (1.17%), Clearbridge Investments LLC (0.56%), JTC Employer Solutions Trustee Ltd (0.20%), Douglas Lane & Associates LLC (0.17%), Morgan Stanley (0.13%) and Envestnet Asset Management Inc. (0.13%).

How do I buy shares of Haleon?

Shares of HLN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull , Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here .

Haleon Stock Price, News & Analysis (NYSE:HLN)

$8.58

+0.02 (+0.23%)

(As of 12/1/2023 ET)

Compare

Today's Range: $8.49
▼
$8.60
50-Day Range: $7.78
▼
$8.63
52-Week Range: $7.01
▼
$9.05

Volume: 4.77 million shs
Average Volume: 3.62 million shs
Market Capitalization: $39.62 billion

P/E Ratio: N/A
Dividend Yield: 1.05%
Price Target: N/A

Haleon MarketRank™ Stock Analysis

Analyst Rating: N/A
Upside/Downside: N/A
Short Interest: Healthy
0.44% of Float Sold Short
Dividend Strength: Weak
Based on Four Factors
Sustainability: N/A
News Sentiment: 0.74
Based on 4 Articles This Week
Insider Trading: N/A
Proj. Earnings Growth: 8.89%
From $0.45 to $0.49 Per Share

Overall MarketRank^™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.54 out of 5 stars

Medical Sector

878th out of 953 stocks

Toilet Preparations Industry

12th out of 13 stocks

N/A

Analyst's Opinion

Consensus Rating
There is not enough analysis data for Haleon.

3.0

Short Interest

Percentage of Shares Shorted
0.44% of the float of Haleon has been sold short.
Short Interest Ratio / Days to Cover
Haleon has a short interest ratio ("days to cover") of 4.
Change versus previous month
Short interest in Haleon has recently decreased by 3.42%, indicating that investor sentiment is improving.

1.7

Dividend Strength

Dividend Yield
Haleon pays a meaningful dividend of 1.02%, higher than the bottom 25% of all stocks that pay dividends.
Dividend Growth
Haleon does not have a long track record of dividend growth.
Dividend Sustainability
Based on earnings estimates, Haleon will have a dividend payout ratio of 18.37% next year. This indicates that Haleon will be able to sustain or increase its dividend.

N/A

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
There is no current Upright™ data available for HLN.

2.1

News and Social Media Coverage

News Sentiment
Haleon has a news sentiment score of 0.74. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.
News Coverage This Week
MarketBeat has tracked 4 news articles for Haleon this week, compared to 2 articles on an average week.
Search Interest
Only 3 people have searched for HLN on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.
MarketBeat Follows
Only 1 people have added Haleon to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days.

0.0

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Haleon insiders have not sold or bought any company stock.
Percentage Held by Institutions
Only 6.67% of the stock of Haleon is held by institutions.

1.3

Earnings and Valuation

Earnings Growth
Earnings for Haleon are expected to grow by 8.89% in the coming year, from $0.45 to $0.49 per share.
Price to Earnings Growth Ratio
Haleon has a PEG Ratio of 2.92. PEG Ratios above 1 indicate that a company could be overvalued.
Price to Book Value per Share Ratio
Haleon has a P/B Ratio of 1.95. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

About Haleon Stock (NYSE:HLN)

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, minerals, and supplements. Its portfolio of brands includes Advil, Sensodyne, Panadol, Voltaren, Theraflu, Otrivin, Polident, parodontax, and Centrum. The company was formerly known as DRVW 2022 plc and changed its name to Haleon plc in February 2022. Haleon plc was incorporated in 2021 and is headquartered in Weybridge, the United Kingdom.

HLN Stock Price History

30 days | 90 days | 365 days | Advanced Chart

HLN Stock News Headlines

December 3, 2023 | americanbankingnews.com

Haleon (NYSE:HLN) Sees Strong Trading Volume

December 1, 2023 | benzinga.com

Looking Into Haleon's Recent Short Interest

December 3, 2023 | Wealthpress (Ad)

Trading Experts Call It “The Perfect Tesla Trade”

Thanks to a new discovery linked to shares of Tesla, regular folks can now target gains of 100% or more in six days or less. New research shows it’s happened 23 different times this year. The next trade is scheduled for this Thursday.

November 28, 2023 | msn.com

1 Pharma Stock to Buy on Strong Vaccine Growth Potential

November 26, 2023 | americanbankingnews.com

Critical Analysis: Oddity Tech (NASDAQ:ODD) & Haleon (NYSE:HLN)

November 23, 2023 | seekingalpha.com

Haleon's Long-Term Growth Prospects Look Healthy On Solid Macro Trends

November 20, 2023 | seekingalpha.com

Haleon: A Stable Pick

November 7, 2023 | msn.com

The Haleon share price is stuck at £3! Should I invest?

December 3, 2023 | DTI Trader (Ad)

All the trading advice you’ve ever received boils down to this

All the trading advice you’ve ever received boils down to one goal and one goal only: finding a reliable edge in the markets. If you can do that, grab hold of it and never let go. Because once you have that edge, and you can count on it, you never need to do anything else.

November 2, 2023 | lse.co.uk

TOP NEWS: Haleon maintains full-year guidance as profit edges up

November 2, 2023 | nl.investing.com

HALEON ADR winst en omzet lager dan voorspeld

November 2, 2023 | msn.com

Advil maker Haleon's quarterly revenue rises on price hikes, strong demand

October 20, 2023 | msn.com

CVS pulling OTC cold medicines containing nasal decongestant phenylephrine

October 20, 2023 | msn.com

CVS Pulls Some Cold Medicines From Its Shelves. What It Means for Stocks.

August 24, 2023 | finance.yahoo.com

Haleon plc: Recent weakness provides buying opportunity

August 2, 2023 | seekingalpha.com

Haleon plc 2023 Q2 - Results - Earnings Call Presentation

July 26, 2023 | reuters.com

GSK raises 2023 outlook boosted by vaccine, HIV drug sales

July 17, 2023 | finance.yahoo.com

Returns Are Gaining Momentum At Haleon (LON:HLN)

July 14, 2023 | proactiveinvestors.com

Haleon reportedly plans sweeping jobs cuts

July 12, 2023 | msn.com

A Look Into Haleon Inc's Price Over Earnings

June 29, 2023 | seekingalpha.com

Haleon: Leading Business In An Attractive Industry

June 11, 2023 | seekingalpha.com

Haleon: A Hidden Gem In The Consumer Health Market

June 2, 2023 | finance.yahoo.com

Does The Market Have A Low Tolerance For Haleon plc's (LON:HLN) Mixed Fundamentals?

May 24, 2023 | wsj.com

Haleon PLC

May 12, 2023 | msn.com

GSK cuts its Haelon stake in $1B share sale

May 5, 2023 | seekingalpha.com

Haleon: Brand Portfolio Strength Keeps Us Bullish

April 19, 2023 | proactiveinvestors.com

Haleon profit margin may disappoint, says Barclays

See More Headlines

Receive HLN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Haleon and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Ex-Dividend for 10/5 Dividend: 8/24/2023
Dividend Payable: 10/05/2023
Last Earnings: 11/02/2023
Today: 12/02/2023
Fiscal Year End: 12/31/2023
Next Earnings (Estimated): 3/18/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NYSE
Industry: Toilet preparations
Sub-Industry: N/A
Sector: Medical
Current Symbol: NYSE:HLN
CUSIP: N/A
CIK: 1900304
Web: www.haleon.com
Phone: 44-19-3282-2000
Fax: N/A
Employees: 24,622
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: 19.07
P/E Growth: 2.91
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: 0.53
Current Ratio: 0.84
Quick Ratio: 0.54

Sales & Book Value

Annual Sales: $13.43 billion
Price / Sales: 2.95
Cash Flow: $0.36 per share
Price / Cash Flow: 23.72
Book Value: $4.41 per share
Price / Book: 1.95

Miscellaneous

Outstanding Shares: 4,617,290,000
Free Float: N/A
Market Cap: $39.62 billion
Optionable: Not Optionable
Beta: 0.33

(Almost) Everything You Need To Know About The EV Market

Click the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise.

Get This Free Report

Key Executives

Mr. Brian McNamara (Age 56)
CEO & Executive Director
Comp: $2.93M
Mr. Tobias Hestler (Age 50)
CFO & Executive Director
Comp: $1.25M
Ms. Amy Landucci
Chief Digital & Technology Officer
Ms. Sonya Ghobrial (Age 49)
Head of Investor Relations
Mr. Bjarne Philip Tellmann (Age 56)
General Counsel
Ms. Tamara Rogers (Age 53)
Chief Marketing Officer
Ms. Mairead Nayager (Age 48)
Chief Human Resources Officer
Mr. Bart Derde (Age 53)
Chief Supply Chain Officer
Mr. Filippo Lanzi
President of EMEA & LatAm
Ms. Teri Lyng (Age 60)
Head of Transformation & Sustainability

Key Competitors

View All Competitors

Institutional Ownership

View All Institutional Transactions

HLN Stock Analysis - Frequently Asked Questions

Should I buy or sell Haleon stock right now?: 6 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Haleon in the last year. There are currently 2 hold ratings and 4 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" HLN shares.
View HLN analyst ratings or view top-rated stocks.
How have HLN shares performed in 2023?: Haleon's stock was trading at $8.00 at the beginning of the year. Since then, HLN shares have increased by 7.3% and is now trading at $8.58.
View the best growth stocks for 2023 here.
Are investors shorting Haleon?: Haleon saw a drop in short interest during the month of October. As of October 31st, there was short interest totaling 21,050,000 shares, a drop of 7.1% from the October 15th total of 22,660,000 shares. Based on an average trading volume of 5,310,000 shares, the days-to-cover ratio is currently 4.0 days. Approximately 0.5% of the shares of the stock are sold short.
View Haleon's Short Interest.
When is Haleon's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Monday, March 18th 2024.
View our HLN earnings forecast.
How were Haleon's earnings last quarter?: Haleon plc (NYSE:HLN) released its quarterly earnings results on Thursday, November, 2nd. The company reported $0.10 earnings per share for the quarter. The firm earned $3.54 billion during the quarter.
How often does Haleon pay dividends? What is the dividend yield for Haleon?: Haleon announced a -- dividend on Wednesday, August 2nd. Shareholders of record on Friday, August 25th will be paid a dividend of $0.046 per share on Thursday, October 5th. This represents a yield of 1.3%. The ex-dividend date is Thursday, August 24th.
Read our dividend analysis for HLN.

Is Haleon a good dividend stock?: Haleon (NYSE:HLN) pays an annual dividend of $0.09 per share and currently has a dividend yield of 1.02%.
Read our dividend analysis for HLN.
What ETFs hold Haleon's stock?: ETFs with the largest weight of Haleon (NYSE:HLN) stock in their portfolio include VanEck Pharmaceutical ETF (PPH), Pacer BioThreat Strategy ETF (VIRS), ClearBridge Focus Value ESG ETF (CFCV), Horizon Kinetics Medical ETF (MEDX),
Who are Haleon's major shareholders?: Haleon's stock is owned by many different retail and institutional investors. Top institutional investors include FMR LLC (1.17%), Clearbridge Investments LLC (0.56%), JTC Employer Solutions Trustee Ltd (0.20%), Douglas Lane & Associates LLC (0.17%), Morgan Stanley (0.13%) and Envestnet Asset Management Inc. (0.13%).
How do I buy shares of Haleon?: Shares of HLN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

This page (NYSE:HLN) was last updated on 12/3/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial